Literature DB >> 4064578

The effect of hypoglycaemia on visual function: a clinical and electrophysiological study.

R A Harrad, C S Cockram, A P Plumb, S Stone, P Fenwick, P H Sönksen.   

Abstract

Disturbance of vision commonly accompanies hypoglycaemia. This study was designed to investigate the nature of the visual disturbance, the blood glucose threshold at which the disturbance occurred and the physiological basis. Measurements were made of the corrected visual acuity, colour vision (100 Hue test), visual evoked potentials (VEP), electroencephalography (EEG) frequency analysis and psychometry (digit recall) during stepwise induction of controlled hypoglycaemia produced by an intravenous insulin infusion. Six male volunteers and five insulin-dependent diabetic subjects were studied. During hypoglycaemia corrected visual acuity was unchanged. Colour vision was significantly impaired. Baseline VEP were normal in both groups but significantly prolonged during hypoglycaemia (mean increment 10.8 ms) and increased by greater than 5 ms in nine out of 11 subjects. Quantitative EEG analysis demonstrated slowing with a power density spectral shift from fast alpha to slow alpha, theta and delta which correlated with VEP latency and amplitude changes. The findings have clinical implications. A deterioration in colour vision is likely to impair the ability to read reagent strips by eye. VEP measurements in diabetic patients are likely to be misleading if hypoglycaemia is present; EEG changes are a sensitive index of cortical dysfunction during hypoglycaemia and provide a theoretical basis for developing a portable device to detect early hypoglycaemia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4064578     DOI: 10.1042/cs0690673

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  17 in total

1.  Neurophysiological changes during insulin-induced hypoglycaemia and in the recovery period following glucose infusion in type 1 (insulin-dependent) diabetes mellitus and in normal man.

Authors:  G Tallroth; M Lindgren; G Stenberg; I Rosen; C D Agardh
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

2.  Human photopic response to circulating glucose.

Authors:  W W Dawson; K Hazariwala; S Karges
Journal:  Doc Ophthalmol       Date:  2000-09       Impact factor: 2.379

3.  Neural dysfunction during hypoglycaemia.

Authors:  T H Koh; A Aynsley-Green; M Tarbit; J A Eyre
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

4.  Hypoglycaemia in patients with insulin dependent diabetes.

Authors:  I Sturgess; P Fenwick; P H Sönksen; C S Cockram
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-30

5.  Effects of hyperglycaemia on visual evoked potentials in insulin-dependent diabetic patients.

Authors:  V Martinelli; P M Piatti; M Filippi; M Pacchioni; M R Pastore; N Canal; G Comi
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

6.  Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia.

Authors:  K M MacLeod; D A Hepburn; I J Deary; G M Goodwin; N Dougall; K P Ebmeier; B M Frier
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

Review 7.  Hypoglycemia-Induced Changes in the Electroencephalogram: An Overview.

Authors:  Lykke Blaabjerg; Claus B Juhl
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

8.  Monitoring set-up for selection of parameters for detection of hypoglycaemia in diabetic patients.

Authors:  G Heger; K Howorka; H Thoma; G Tribl; J Zeitlhofer
Journal:  Med Biol Eng Comput       Date:  1996-01       Impact factor: 2.602

9.  Extent of foveal tritanopia in diabetes mellitus.

Authors:  N Davies; A Morland
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

10.  Effect of short term changes in blood glucose on visual pathway function in insulin dependent diabetes.

Authors:  K J Hardy; M O Scase; D H Foster; J H Scarpello
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.